Baerbel R. Brown
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Inflammatory mediators and NSAID effects, Chemical Synthesis and Analysis, Peptidase Inhibition and Analysis, Protein Hydrolysis and Bioactive Peptides, Receptor Mechanisms and Signaling
Most-Cited Works
- → Dual Metalloprotease Inhibitors. 6. Incorporation of Bicyclic and Substituted Monocyclic Azepinones as Dipeptide Surrogates in Angiotensin-Converting Enzyme/Neutral Endopeptidase Inhibitors(1996)60 cited
- → Identification of purine inhibitors of phosphodiesterase 7 (PDE7)(2004)50 cited
- → Interphenylene 7-oxabicyclo[2.2.1]heptane thromboxane A2(TxA2)antagonists. Semicarbazone .omega.-chains(1991)36 cited
- → Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists(1993)28 cited
- → Dual metalloprotease inhibitors. IV. Utilization of thiazepines and thiazines as constrained peptidomimetic surrogates in mercaptoacyl dipeptides(1994)22 cited
- → Thromboxane receptor antagonist BMS-180291: A new pre-clinical lead(1992)22 cited
- → A general synthesis of dioxolenone prodrug moieties(2002)17 cited
- → Interphenylene 7-oxabicyclo[2.2.1]heptanes. SQ33,961: a new potent, long-acting thromboxane antagonist(1991)7 cited
- → Interphenylene phenyl oxazoles: novel, potent thromboxane receptor antagonists(1992)1 cited
- → ChemInform Abstract: Dual Metalloprotease Inhibitors. Part 6. Incorporation of Bicyclic and Substituted Monocyclic Azepinones as Dipeptide Surrogates in Angiotensin‐Converting Enzyme (ACE)/Neutral Endopeptidase (NEP) Inhibitors.(1996)